← Home
Eli Lilly CEO

David Ricks

CEO of pharmaceutical company Eli Lilly. Argues that GLP-1 drugs could prove more transformative than artificial intelligence in the near term.

Known For

GLP-1 drug developmentpharmaceutical leadershipcontrarian tech assessment

Episodes

#The Week: AI, GLP-1s, and Scott's Iran War ReversalJun 5, 2026#Why People Are Losing Faith in HealthcareJun 4, 2026